ChartMill assigns a Buy % Consensus number of 82% to CATX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-21 | UBS | Maintains | Buy -> Buy |
| 2025-11-18 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-10-13 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-10 | BTIG | Initiate | Buy |
| 2025-10-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-23 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-06-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-06-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-04-07 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-03-27 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | HC Wainwright & Co. | Initiate | Buy |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-01-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-25 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-11-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-24 | UBS | Initiate | Buy |
| 2024-10-24 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-10-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-10-01 | Wedbush | Initiate | Outperform |
| 2024-09-25 | Truist Securities | Initiate | Buy |
| 2024-09-10 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-06 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-03 | Cantor Fitzgerald | Reiterate | Overweight |
19 analysts have analysed CATX and the average price target is 12.63 USD. This implies a price increase of 395.38% is expected in the next year compared to the current price of 2.55.
The consensus rating for PERSPECTIVE THERAPEUTICS INC (CATX) is 82.1053 / 100 . This indicates that analysts generally have a positive outlook on the stock.